Bionano Genomics, Inc. Common Stock vs. Bruker Corporation
Bionano Genomics, Inc. Common Stock and Bruker Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BNGO | BRKR | |
|---|---|---|
| Market Cap | $14.13 million | $9.61 billion |
| Revenue (TTM) | $30.18 million | $3.50 billion |
| Net Income (TTM) | $-32,162,000 | $-64,500,000 |
BRKR leads on 2 of 3 size & scale factors.
Valuation
| BNGO | BRKR | |
|---|---|---|
| Price / Book | 0.45 | 4.00 |
| Price / Sales | 0.47 | 2.74 |
BNGO leads on 2 of 2 valuation factors.
Profitability
| BNGO | BRKR | |
|---|---|---|
| Net Margin | -106.58% | -1.84% |
| Return on Equity | -101.76% | -2.69% |
BRKR leads on 2 of 2 profitability factors.
Dividend
| BNGO | BRKR | |
|---|---|---|
| Dividend Yield | — | 0.33% |
BNGO and BRKR split the dividend factors evenly.
Risk & Sentiment
| BNGO | BRKR | |
|---|---|---|
| Short Interest | 0.15% | 1.53% |
BNGO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BNGO overview, BNGO financials, BRKR overview, BRKR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.